impact:

takeda.co.jp

The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. More information...

According to PR-model, takeda.co.jp is ranked 17,635th in multilingual Wikipedia, in particular this website is ranked 1,105th in Japanese Wikipedia.

The website is placed before nexos.com.mx and after ercrugby.com in the BestRef global ranking of the most important sources of Wikipedia.

#Language
PR-model F-model AR-model
17,635th place
78,033rd place
58,552nd place
1,105th place
5,159th place
2,754th place
51,824th place
78,962nd place
60,056th place
frFrench
194,672nd place
460,243rd place
269,933rd place
arArabic
133,628th place
264,371st place
189,216th place